tiprankstipranks
Anika Therapeutics (ANIK)
NASDAQ:ANIK
US Market

Anika Therapeutics (ANIK) Income Statement

Compare
155 Followers

Anika Therapeutics Income Statement

Last quarter (Q3 2024), Anika Therapeutics's total revenue was $38.75M, a decrease of -6.54% from the same quarter last year. In Q3, Anika Therapeutics's net income was $-29.92M. See Anika Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 166.66M$ 156.24M$ 147.79M$ 130.46M$ 114.61M
Gross Profit
$ 103.09M$ 93.58M$ 82.94M$ 69.03M$ 85.86M
Operating Expenses
$ 191.47M$ 112.98M$ 101.42M$ 83.49M$ 51.62M
Depreciation and Amortization
$ 14.22M$ 16.35M$ 15.99M$ 14.99M$ 7.17M
EBITDA
$ -11.23M$ -4.91M$ 2.62M$ -12.83M$ 34.25M
Operating Income
$ -87.64M$ -19.40M$ -18.48M$ -14.47M$ 34.25M
Other Income/Expenses
$ 2.31M$ 654.00K$ -188.00K$ -302.00K$ 1.87M
Pretax Income
$ -85.33M$ -18.75M$ 2.43M$ -28.62M$ 36.12M
Net Income
$ -82.67M$ -14.86M$ 4.13M$ -23.98M$ 27.19M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.64$ -1.02$ 0.29$ -1.69$ 1.93
Diluted EPS
$ -5.64$ -1.02$ 0.28$ -1.69$ 1.89
Weighted Average Shares Outstanding
14.66M 14.56M 14.40M 14.22M 14.12M
Weighted Average Shares Outstanding (Diluted)
14.66M 14.56M 14.63M 14.22M 14.37M
Currency in USD

Anika Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis